Compare AMC ENTERTAINMENT HOLDINGS, INC. (AMC) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AMC ENTERTAINMENT HOLDINGS, INC. vs Neurocrine Biosciences Inc — how do they compare? AMC ENTERTAINMENT HOLDINGS, INC. trades at $2.39 (market cap $2.14B), while Neurocrine Biosciences Inc trades at $157.76 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 7.7× AMC ENTERTAINMENT HOLDINGS, INC.'s market cap, and AMC ENTERTAINMENT HOLDINGS, INC. pays a 0.11% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| AMC | NBIX | |
|---|---|---|
Market Cap | $2.14B | $16.46B |
Sector | Media | Health |
52-Week High | $3.15 | $185.50 |
52-Week Low | $0.95 | $123.10 |
Enterprise Value | $9.08B | $16.48B |
Dividend Yield | 0.11% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AMC ENTERTAINMENT HOLDINGS, INC.
AMC Entertainment Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides theatrical exhibition, movie screening, food distribution, online ticket booking, and other related services. AMC Entertainment offers movie theaters worldwide.
Read more on AMC →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
